Among these, cTn is acknowledged as a biomarker for assessing the risk of acute coronary syndrome (ACS), including cardiac troponin T (cTnT) and cardiac troponin I (cTnI) (178). The gene discussed is TNNI3; the disease is acute coronary syndrome.